Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription

ABSTRACT Tat stimulates human immunodeficiency virus type 1 (HIV-1) transcriptional elongation by recruitment of carboxyl-terminal domain (CTD) kinases to the HIV-1 promoter. Using an immobilized DNA template assay, we have analyzed the effect of Tat on kinase activity during the initiation and elongation phases of HIV-1 transcription. Our results demonstrate that cyclin-dependent kinase 7 (CDK7) (TFIIH) and CDK9 (P-TEFb) both associate with the HIV-1 preinitiation complex. Hyperphosphorylation of the RNA polymerase II (RNAP II) CTD in the HIV-1 preinitiation complex, in the absence of Tat, takes place at CTD serine 2 and serine 5. Analysis of preinitiation complexes formed in immunodepleted extracts suggests that CDK9 phosphorylates serine 2, while CDK7 phosphorylates serine 5. Remarkably, in the presence of Tat, the substrate specificity of CDK9 is altered, such that the kinase phosphorylates both serine 2 and serine 5. Tat-induced CTD phosphorylation by CDK9 is strongly inhibited by low concentrations of 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole, an inhibitor of transcription elongation by RNAP II. Analysis of stalled transcription elongation complexes demonstrates that CDK7 is released from the transcription complex between positions +14 and +36, prior to the synthesis of transactivation response (TAR) RNA. In contrast, CDK9 stays associated with the complex through +79. Analysis of CTD phosphorylation indicates a biphasic modification pattern, one in the preinitiation complex and the other between +36 and +79. The second phase of CTD phosphorylation is Tat-dependent and TAR-dependent. These studies suggest that the ability of Tat to increase transcriptional elongation may be due to its ability to modify the substrate specificity of the CDK9 complex.

[1]  B. Cullen,et al.  Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Hoeijmakers,et al.  The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor , 1994, Cell.

[3]  R. Kornberg,et al.  CTD kinase associated with yeast RNA polymerase II initiation factor b , 1991, Cell.

[4]  J. Hoeijmakers,et al.  TFIIH: a key component in multiple DNA transactions. , 1996, Current opinion in genetics & development.

[5]  F. H. Espinoza,et al.  Control of eukaryotic cell cycle progression by phosphorylation of cyclin-dependent kinases. , 1998, The cancer journal from Scientific American.

[6]  E. Lees,et al.  Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. , 1996, Oncogene.

[7]  J. Corden,et al.  Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2 , 1989, Nature.

[8]  R. Young,et al.  Association of Cdk-activating kinase subunits with transcription factor TFIIH , 1995, Nature.

[9]  M. Wahi,et al.  Identification of genes required for alpha 2 repression in Saccharomyces cerevisiae. , 1995, Genetics.

[10]  M. Mathews,et al.  Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate , 1999, Journal of Virology.

[11]  D. Bentley,et al.  Transcriptional control: Tat cofactors and transcriptional elongation , 1998, Current Biology.

[12]  M. Garber,et al.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.

[13]  M. Mathews,et al.  Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. , 1990, Genes & development.

[14]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[15]  D. Chen,et al.  Tat Activates Human Immunodeficiency Virus Type 1 Transcriptional Elongation Independent of TFIIH Kinase , 1999, Molecular and Cellular Biology.

[16]  S. Elledge,et al.  The role of Cdk7 in CAK function, a retro-retrospective. , 1998, Genes & development.

[17]  D. Chen,et al.  Transcription elongation factor P‐TEFb mediates Tat activation of HIV‐1 transcription at multiple stages , 1998, The EMBO journal.

[18]  J. M. Lee,et al.  CTD kinase large subunit is encoded by CTK1, a gene required for normal growth of Saccharomyces cerevisiae. , 1991, Gene expression.

[19]  R. E. Esposito,et al.  Identification of negative regulatory genes that govern the expression of early meiotic genes in yeast. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Okamoto,et al.  Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Price.  P-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II , 2000, Molecular and Cellular Biology.

[22]  J. Karn,et al.  Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. , 1999, Journal of molecular biology.

[23]  M. J. Mallory,et al.  Stress and developmental regulation of the yeast C‐type cyclin Ume3p (Srb11p/Ssn8p) , 1997, The EMBO journal.

[24]  M. Dahmus.  Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II* , 1996, The Journal of Biological Chemistry.

[25]  R. Gaynor,et al.  Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. , 1999, Journal of molecular biology.

[26]  J. Bartek,et al.  Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase) , 1994, The Journal of cell biology.

[27]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[28]  Richard A. Young,et al.  An RNA polymerase II holoenzyme responsive to activators , 1994, Nature.

[29]  B. Cullen,et al.  Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV‐1 Tat , 1998, The EMBO journal.

[30]  D. Reinberg,et al.  NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. , 1998, Molecular cell.

[31]  A. Rice,et al.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor , 1995, Journal of virology.

[32]  C. Ho,et al.  Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. , 1999, Molecular cell.

[33]  R. Berezney,et al.  Growth-related Changes in Phosphorylation of Yeast RNA Polymerase II* , 1998, The Journal of Biological Chemistry.

[34]  R. Young,et al.  Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. , 1998, Molecular cell.

[35]  T. Hunt,et al.  Cell cycle regulation of the p34cdc2/p33cdk2-activating kinase p40MO15. , 1994, Journal of cell science.

[36]  M. Carlson,et al.  Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Reinberg,et al.  Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II , 1992, Nature.

[38]  R. Roeder,et al.  A novel RNA polymerase II‐containing complex potentiates Tat‐enhanced HIV‐1 transcription , 1999, The EMBO journal.

[39]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[40]  D M Crothers,et al.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA. , 1990, Science.

[41]  J. Karn,et al.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Bentley,et al.  Regulation of CDK7 substrate specificity by MAT1 and TFIIH , 1997, The EMBO journal.

[43]  N. Thompson,et al.  Inhibition of in vivo and in vitro transcription by monoclonal antibodies prepared against wheat germ RNA polymerase II that react with the heptapeptide repeat of eukaryotic RNA polymerase II. , 1989, The Journal of biological chemistry.

[44]  R. Roeder,et al.  Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain , 1996, Nature.

[45]  D. Sterner,et al.  The yeast carboxyl-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex , 1995, Molecular and cellular biology.

[46]  D. Reinberg,et al.  Cdk-activating kinase complex is a component of human transcription factor TFIIH , 1995, Nature.

[47]  R. Young,et al.  A kinase–cyclin pair in the RNA polymerase II holoenzyme , 1995, Nature.

[48]  M. Morange,et al.  Characterization of the Residues Phosphorylated in Vitro by Different C-terminal Domain Kinases* , 1998, The Journal of Biological Chemistry.

[49]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[50]  B. Peterlin,et al.  Trans-activation by HIV-1 Tat via a heterologous RNA binding protein , 1990, Cell.

[51]  M. Dahmus,et al.  Partial purification and characterization of two distinct protein kinases that differentially phosphorylate the carboxyl-terminal domain of RNA polymerase subunit IIa. , 1993, The Journal of biological chemistry.

[52]  D. Price,et al.  Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation (*) , 1995, The Journal of Biological Chemistry.

[53]  T Lagrange,et al.  The general transcription factors of RNA polymerase II. , 1996, Genes & development.

[54]  J. Corden,et al.  Yeast Carboxyl-terminal Domain Kinase I Positively and Negatively Regulates RNA Polymerase II Carboxyl-terminal Domain Phosphorylation* , 1999, Journal of Biological Chemistry.

[55]  B. Peterlin,et al.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  G. Faye,et al.  The KIN28 gene is required both for RNA polymerase II mediated transcription and phosphorylation of the Rpb1p CTD. , 1995, Journal of molecular biology.

[57]  J. Corden,et al.  Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations. , 1995, Genetics.

[58]  A. Rice,et al.  Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. , 1993, Virology.

[59]  P. Luciw,et al.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product , 1987, Nature.

[60]  A. Rice,et al.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function , 1996, Journal of virology.

[61]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[62]  B. Cullen,et al.  Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function , 1993, Journal of virology.

[63]  A. Yuryev,et al.  Suppression analysis reveals a functional difference between the serines in positions two and five in the consensus sequence of the C-terminal domain of yeast RNA polymerase II. , 1996, Genetics.

[64]  B. Peterlin,et al.  Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. , 1999, Virology.

[65]  J. Egly,et al.  Substrate specificity of the cdk‐activating kinase (CAK) is altered upon association with TFIIH , 1997, The EMBO journal.

[66]  B. Peterlin,et al.  Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells , 1992, Journal of virology.

[67]  D. Reinberg,et al.  Recycling of the general transcription factors during RNA polymerase II transcription. , 1995, Genes & development.

[68]  R. Gaynor,et al.  Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. , 1999, Journal of molecular biology.

[69]  M. Malim,et al.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. , 1992, Genes & development.

[70]  D. Reinberg,et al.  The multifunctional TFIIH complex and transcriptional control. , 1994, Trends in biochemical sciences.

[71]  Bryan R. Cullen,et al.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism , 1986, Cell.

[72]  A. Giordano,et al.  PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[73]  K. Jones,et al.  Taking a new TAK on tat transactivation. , 1997, Genes & development.

[74]  K. Jeang,et al.  Requirements for RNA Polymerase II Carboxyl-terminal Domain for Activated Transcription of Human Retroviruses Human T-Cell Lymphotropic Virus I and HIV-1* , 1996, The Journal of Biological Chemistry.

[75]  R. Kornberg,et al.  Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK , 1994, Cell.

[76]  R. Conaway,et al.  A carboxyl-terminal-domain kinase associated with RNA polymerase II transcription factor delta from rat liver. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[77]  G. Pavlakis,et al.  Expression and characterization of the trans-activator of HTLV-III/LAV virus. , 1986, Science.

[78]  P. O’Farrell,et al.  Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. , 1996, Molecular biology of the cell.

[79]  G. Faye,et al.  The kin28 protein kinase is associated with a cyclin in Saccharomyces cerevisiae. , 1993, Journal of molecular biology.

[80]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[81]  T. Rana,et al.  Tat-associated Kinase (P-TEFb): a Component of Transcription Preinitiation and Elongation Complexes* , 1999, The Journal of Biological Chemistry.

[82]  S. Reed,et al.  KIN28 encodes a C-terminal domain kinase that controls mRNA transcription in Saccharomyces cerevisiae but lacks cyclin-dependent kinase-activating kinase (CAK) activity , 1995, Molecular and cellular biology.

[83]  J. Karn,et al.  Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type‐1 transcription elongation complex , 1997, The EMBO journal.